Clinical trial · Observational
Fecal Metagenomics and Metabolomics Analyses to Identify Potential Screening Biomarkers for Colorectal Polyps and Cancer in Chinese Population
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Many previous studies had revealed that gastrointestinal microbiome is changed compositionally and ecologically in patients with colorectal cancer comparing with healthy population. These finding provide us with a new sight to take advantage of gut microbiota. The current study aims to explore new potential biomarkers for early screening and prognostic prediction of colorectal cancer and colorectal polyps by analyzing metagenomics and metabolomics of gut microbiota.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
| Colorectal Polyp | — | UNRESOLVED | — |
| Gastrointestinal Microbiome | — | UNRESOLVED | — |
| Mass Screening | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Sensitivity and specificity of the screening tool generated from fecal metagenomics and metabolomics data.
- timeFrame
- 12months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. Participants aged 18 to 80 years old. 2. Participants who had been diagnosed with colorectal cancer or advanced colorectal polyps for the first time according to pathology results. 3. Participants who had signed informed consent. 4. Participants must have the ability to complete the questionnaires of the study. Exclusion Criteria: 1. Participants who had a positive personal history of colorectal polyps. 2. Participants who had a positive personal history of colorectal cancer. 3. Participants who had a positive personal history of other gastrointestinal diseases, such as inflammatory bowel disease, intestinal tuberculosis, or irritable bowel syndrome. 4. Participants who had undergone a colonoscopy or other procedure requiring bowel preparation in the last two months. 5. Participants who had been hospitalized for any reason in the last two months. 6. Participants who had consumed antibiotics for any reason in the last three months. 7. Participants who had consumed prebiotic supplements regularly in the last year. 8. Participants who had other physical conditions that didn't suitable to participate in the study, such as severe cardiovascular diseases, serious mental illness, or pregnant status.
References
Publications (0)
Data not yet available